117 related articles for article (PubMed ID: 2334801)
1. [Sensitivity of bone marrow cells damaged by antitumor drugs to cytotoxic action of effectors of a normal spleen].
Klimova MIu; Bogdashin IV; Novitskiĭ VV; Gol'dberg ED
Biull Eksp Biol Med; 1990 Jan; 109(1):60-2. PubMed ID: 2334801
[TBL] [Abstract][Full Text] [Related]
2. [The cytogenetic effects of antitumor preparations with different mechanisms of action].
Khlusova MIu; Novitskiĭ VV; Gol'dberg ED
Eksp Klin Farmakol; 1992; 55(2):49-52. PubMed ID: 1422456
[TBL] [Abstract][Full Text] [Related]
3. [Disorders of bone marrow hematopoiesis long time after the action of cytostatic preparations].
Bogdashin IV; Sycheva EV; Zhdanov VV; Afanas'eva ON; Zapuskalova OP; Novitskiĭ VV; Gol'dberg ED
Biull Eksp Biol Med; 1992 Mar; 113(3):283-4. PubMed ID: 1421227
[TBL] [Abstract][Full Text] [Related]
4. [Long-term consequences of the damaging effect of cytostatic drugs on hematopoiesis and lymphoid tissue].
Gol'dberg ED; Novitskiĭ VV; Zapuskalova OB; Klimova MIu
Vestn Akad Med Nauk SSSR; 1990; (9):52-7. PubMed ID: 2264389
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the effect of cytotoxic agents on agar colony forming cells, spleen colony forming cells, and the erythrocytic repopulating ability of mouse bone marrow.
Millard RE; Blackett NM; Okell SF
J Cell Physiol; 1973 Oct; 82(2):309-17. PubMed ID: 4753424
[No Abstract] [Full Text] [Related]
6. Chromosome aberrations and telomere length modulation in bone marrow and spleen cells of melphalan-treated p53+/- mice.
Sgura A; De Amicis A; Stronati L; Cinelli S; Pacchierotti F; Tanzarella C
Environ Mol Mutagen; 2008 Jul; 49(6):467-75. PubMed ID: 18481314
[TBL] [Abstract][Full Text] [Related]
7. Combined interleukin 1 beta/interleukin 2 treatment in mice: synergistic myelostimulatory activity and protection against cyclophosphamide-induced myelosuppression.
Proietti E; Tritarelli E; Gabriele L; Testa U; Greco G; Pelosi E; Gabbianelli M; Belardelli F; Peschle C
Cancer Res; 1993 Feb; 53(3):569-76. PubMed ID: 8425189
[TBL] [Abstract][Full Text] [Related]
8. [Functional activity of the splenic cells in the late periods after the administration of antitumor preparations with various mechanisms of action].
Zapuskalova OB; Bogdashin IV; Novitskiĭ VV; Gol'dberg ED
Farmakol Toksikol; 1989; 52(1):67-70. PubMed ID: 2707426
[TBL] [Abstract][Full Text] [Related]
9. [The dose-dependent cytogenetic and growth-inhibiting effects of a new antitumor preparation from the nitrosourea group].
Fomina MM; Dzhamanbaev ZhA; Ostrovskaia LA
Izv Akad Nauk SSSR Biol; 1991; (3):436-44. PubMed ID: 1955617
[TBL] [Abstract][Full Text] [Related]
10. Sister chromatid exchanges and chromosome aberrations induced by radiosensitizing agents in bone marrow cells of treated tumor-bearing mice.
Banerjee R; Goldfeder A; Mitra J
J Natl Cancer Inst; 1983 Mar; 70(3):517-21. PubMed ID: 6572740
[TBL] [Abstract][Full Text] [Related]
11. Treatment of mice with stem bark extract of Aphanamixis polystachya reduces radiation-induced chromosome damage.
Jagetia GC; Venkatesha VA
Int J Radiat Biol; 2006 Mar; 82(3):197-209. PubMed ID: 16638717
[TBL] [Abstract][Full Text] [Related]
12. Acceleration of granulopoietic recovery by androgenic steroids in mice made neutropenic by cytotoxic drugs.
Udupa KB; Reissmann KR
Cancer Res; 1974 Oct; 34(10):2517-20. PubMed ID: 4411809
[No Abstract] [Full Text] [Related]
13. [Effect of 1,2:5,6-dianhydrogalactitol and 1,2:5,6-dianhydro-3,4-diacetylgalactitol on DNA synthesis in the cells of melanoma B16, bone marrow, small intestine epithelium, spleen and liver of mice].
Sokolova IS; Elekes I; Otvös L; Gorbacheva LB
Biull Eksp Biol Med; 1984 Sep; 98(9):301-3. PubMed ID: 6487788
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow cells as cytostatic effectors responsible for suppressing leukemia growth in vitro.
Seledtsov VI; Avdeev IV; Seledtsova GV; Samarin DM; Prokopenko IV; Kozlov VA
Biomed Pharmacother; 1995; 49(6):293-9. PubMed ID: 7579011
[TBL] [Abstract][Full Text] [Related]
15. Altered production and renewal of natural killer cells in B-lymphocyte-deficient CBA/N mice.
Miller SC; Christopher FL
Nat Immun Cell Growth Regul; 1989; 8(5):245-54. PubMed ID: 2594018
[TBL] [Abstract][Full Text] [Related]
16. Use of chromosome painting for detecting stable chromosome aberrations induced by melphalan in mice.
Sgura A; Stronati L; Gullotta F; Pecis A; Cinelli S; Lascialfari A; Tanzarella C; Pacchierotti F
Environ Mol Mutagen; 2005 Jun; 45(5):419-26. PubMed ID: 15685603
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of changes in natural cytostatic and cytotoxic activity of mouse spleen cells after treatment with cyclophosphamide and alpha-interferon].
Van'ko LV; Bogdashin IV; Sukhikh GT; Totibadze NV; Fuks BB
Biull Eksp Biol Med; 1986 Aug; 102(8):200-3. PubMed ID: 3488771
[TBL] [Abstract][Full Text] [Related]
18. [Correlation of the sister chromatid exchange level with chromosome aberrations induced by chemical mutagens in vivo].
Shcheglova EG; Chebotarev AN
Biull Eksp Biol Med; 1983 Dec; 96(12):67-9. PubMed ID: 6419793
[TBL] [Abstract][Full Text] [Related]
19. [Spontaneous and induced chromosome aberrations in the bone marrow cells of different strains of mice during aging].
Lil'p IG; Korogodina IuV
Tsitologiia; 1981 Oct; 23(10):1174-9. PubMed ID: 6797115
[TBL] [Abstract][Full Text] [Related]
20. [Suppressive effect of bone marrow cells from normal and leukemic mice on antibody production in culture of spleen cells in vitro].
Sidorovich IG; Pcheliniev SIu; Khalmov RM
Biull Eksp Biol Med; 1980; 89(1):36-8. PubMed ID: 6991020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
